Veracyte Inc (NASDAQ: VCYT) has reported a loss for its third fiscal quarter (ending September 30) of $-0.41 versus a loss $-0.12 for the same period a year ago. This result fell short of the […]
Identiv Inc (NASDAQ: INVE) has reported E.P.S. of $-0.01 for its third fiscal quarter (ending September 30) versus $0.01 for the same period a year ago — a decline of -200%. This result fell short […]
On 11/7/23, MacroGenics Inc (NASDAQ: MGNX) stock enjoyed a major increase of 17.1%, closing at $6.37. The stock has risen 23.4% during the last week but has been weak relative to the market over the […]
Gogo Inc (NASDAQ: GOGO) has reported E.P.S. of $0.16 for its third fiscal quarter (ending September 30) versus $0.16 for the same period a year ago — flat performance. This performance was $0.01 better than […]
The Andersons Inc (NASDAQ: ANDE) has reported earnings for its third fiscal quarter (ending September 30) of $0.29 versus $0.51 for the same period a year ago — a decline of -43%. This result fell […]
NETGEAR Inc (NASDAQ: NTGR) has recently experienced meaningful negative changes in fundamentals: significant quarterly sales deceleration occurred, significant quarterly earnings deceleration occurred, and the consensus estimate for December, 2024 decreased significantly. Recent meaningful negative changes […]
Great Lakes Dredge & Dock Corp (NASDAQ: GLDD) stock suffered a major decline of -13.6% on 11/7/23. The shares closed at $6.48. The stock has been exceptionally strong relative to the market over the last […]
On 11/7/23, Neogenomics Inc (NASDAQ: NEO) stock enjoyed a major increase of 14.2%, closing at $16.73. Relative to the market the stock has been weak over the last nine months but has risen 22.9% during […]
ICU Medical Inc (NASDAQ: ICUI) stock suffered a major decline of -17.3% on 11/7/23. The shares closed at $84.34. The stock has declined -14.3% during the last week and has been extremely weak relative to […]
For its third fiscal quarter (ending September 30), Gilead Sciences Inc (NASDAQ: GILD) has reported a 22% increase in E.P.S. from $1.43 a year ago to $1.75 in the current quarter. However, this performance was […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research